Inventor · disambiguated record
Yang-Xin Fu
Also filed as: FU YANG · FU YANG-XIN
21 granted patents·17 pending applications·60 citations·filing 2003–2024
93Inventor score
Files withUNIV CHICAGO9FU YANG-XIN5SABIC GLOBAL TECHNOLOGIES BV5UNIV TEXAS5HANGZHOU SINGCLEAN MED PROD CO LTD4
Top patents by PatentIndex Score
38 records- 0193US8263081B2Antibody-light fusion products for cancer therapeuticsFU YANG-XIN·Filed 2008·Granted Sep 11, 2012·14 cites·23 claims
- 0292US9623116B2Antibody-light fusion products for cancer therapeuticsUNIV CHICAGO·Filed 2015·Granted Apr 18, 2017·5 cites·8 claims
- 0391US7811983B2Increased T-cell tumor infiltration and eradication of metastases by mutant lightUNIV CHICAGO·Filed 2006·Granted Oct 12, 2010·7 cites·8 claims
- 0490US12121907B1Cyclical and continuous device and method for wet sieving of polysaccharide granulesHANGZHOU SINGCLEAN MED PROD CO LTD·Filed 2023·Granted Oct 22, 2024·3 cites·7 claims
- 0589US9061073B2Antibody-light fusion products for cancer therapeuticsFU YANG-XIN·Filed 2012·Granted Jun 23, 2015·6 cites·3 claims
- 0687US10421971B2Anti-tumor therapyUNIV CHICAGO·Filed 2014·Granted Sep 24, 2019·9 cites·18 claims
- 0784US10995206B2Composition comprising heterophasic propylene copolymerSABIC GLOBAL TECHNOLOGIES BV·Filed 2016·Granted May 4, 2021·2 cites·18 claims
- 0884US9493532B2Compositions for cancer therapy using mutant light molecules with increased affinity to receptorsUNIV CHICAGO·Filed 2012·Granted Nov 15, 2016·6 cites·4 claims
- 0978US11332604B2Composition comprising heterophasic propylene copolymerSABIC GLOBAL TECHNOLOGIES BV·Filed 2018·Granted May 17, 2022·1 cites·16 claims
- 1077US10956847B2Risk identification based on historical behavioral dataADVANCED NEW TECHNOLOGIES CO LTD·Filed 2017·Granted Mar 23, 2021·2 cites·20 claims
- 1174US9272025B2Increased T-cell tumor infiltration and eradication of metastases by mutant lightFU YANG-XIN·Filed 2010·Granted Mar 1, 2016·1 cites·1 claims
- 1273US7807784B2Increased T-cell tumor infiltration by mutant LIGHTUNIV CHICAGO·Filed 2004·Granted Oct 5, 2010·3 cites·4 claims
- 1370US2024125791A1Screening method for amino acid sequence of protein nanopore, protein nanopore, and applications thereofUNIV SOUTHERN SCI & TECH·Filed 2023·Application pending·0 cites
- 1469US2024424013A1SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPYUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1567US12441781B2Interleukin 15 fusion proteins, and compositions and therapeutic methods thereofIMMUNE TARGETING INC·Filed 2019·Granted Oct 14, 2025·1 cites·21 claims
- 1661US12097213B2Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapyUNIV TEXAS·Filed 2021·Granted Sep 24, 2024·0 cites·16 claims
- 1760US12030961B2Method for removing organic solvent from starch hemostatic microspheresHANGZHOU SINGCLEAN MED PROD CO LTD·Filed 2021·Granted Jul 9, 2024·0 cites·2 claims
- 1859US2009068193A1Treatment And Prophylaxis With 4-1BB-Binding AgentsCHEN LIEPING·Filed 2008·Application pending·0 cites
- 1958US2016317631A1Increased t-cell tumor infiltration and eradication of metastases by mutant lightUNIV CHICAGO·Filed 2016·Application pending·0 cites
- 2058US2009093429A1Combination therapy for treating cancerFU YANG-XIN·Filed 2008·Application pending·0 cites
- 2157US11072698B2Composition comprising heterophasic propylene copolymerSABIC GLOBAL TECHNOLOGIES BV·Filed 2018·Granted Jul 27, 2021·0 cites·18 claims
- 2257US2022302446A1Zinc ion battery positive electrode material, preparation method therefor, and application thereofREHAB QINGDAO ENERGY TECH CO LTD·Filed 2022·Application pending·0 cites
- 2356US2024182727A1Coating composition, its preparation and use in reducing heat gainUNIV CITY HONG KONG·Filed 2022·Application pending·0 cites
- 2453US10167328B2Methods for cancer therapy using mutant light molecules with increased affinity to receptorsUNIV CHICAGO·Filed 2016·Granted Jan 1, 2019·0 cites·9 claims
- 2553US2023067215A1Gel for Injection Containing Controlled Degradation Polyester MicrospheresHANGZHOU SINGCLEAN MED PROD CO LTD·Filed 2021·Application pending·0 cites
- 2652US11091618B2Polypropylene compositionSABIC GLOBAL TECHNOLOGIES BV·Filed 2018·Granted Aug 17, 2021·0 cites·19 claims
- 2751US12486389B2Heterophasic propylene copolymer compositionSABIC GLOBAL TECHNOLOGIES BV·Filed 2020·Granted Dec 2, 2025·0 cites·18 claims
- 2851US2022064436A1Gradient Injection Comprising a Mixture of Polymer MicrospheresHANGZHOU SINGCLEAN MED PROD CO LTD·Filed 2021·Application pending·0 cites
- 2951US2024145690A1Positive electrode material, preparation method therefor, and application thereofREHAB CHANGZHOU ENERGY TECH CO LTD·Filed 2021·Application pending·0 cites
- 3050US2024049093A1Network device, method and computer readable medium for accessing external networksARRIS ENTPR LLC·Filed 2022·Application pending·0 cites
- 3150US2004109847A1Treatment and prophylaxis with 4-1BB-binding agentsFiled 2003·Application pending·0 cites
- 3248US2022160703A1Tumor-selective combination therapyUNIV TEXAS·Filed 2020·Application pending·0 cites
- 3345US2012014947A1Methods and compositions to reduce liver damage associated with conditions or therapies that affect the immune systemFU YANG-XIN·Filed 2011·Application pending·0 cites
- 3445US2020123227A1Interferon prodrug for the treatment of cancerUNIV TEXAS·Filed 2018·Application pending·0 cites
- 3544US2016250327A1Methods and compositions to reduce liver damage associated with conditions or therapies that affect the immune systemUNIV CHICAGO·Filed 2016·Application pending·0 cites
- 3643US2015157692A1Methods of treating obesityUNIV CHICAGO·Filed 2013·Application pending·0 cites
- 3737US11376324B2Sting activating nanovaccine for immunotherapyUNIV TEXAS·Filed 2017·Granted Jul 5, 2022·0 cites·23 claims
- 3836US12473337B2Homodimeric or heterodimeric interleukin 12 fusion proteins, and compositions and therapeutic methods thereofSHANGHAI KANGABIO CO LTD·Filed 2019·Granted Nov 18, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Yang-Xin Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →